$11.81
-0.07[-0.59%]
At close: Apr 26
$11.81
0[0.00%]
After Hours: 4:20PM EDT
Pliant Therapeutics
(NASDAQ:PLRX)Pliant Therapeutics Stock (NASDAQ:PLRX), Insider Trading Activity
Pliant Therapeutics: Insider buying and selling updated today.
Shares Outstanding
60.319M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | Lamont Keith Cummings | CHIEF FINANCIAL OFFICER | -9.781K | $17.23 | -$168.53K | SELL | -4.79% | 194.605K | Jan 17 | View |
| Jan 19, 2024 | Hans Hull | CHIEF BUSINESS OFFICER | -9.786K | $17.23 | -$168.61K | SELL | -4.69% | 199.054K | Jan 17 | View |
| Jan 19, 2024 | Bernard Coulie | PRESIDENT AND CEO | -25.721K | $17.23 | -$443.17K | SELL | -3.42% | 725.699K | Jan 17 | View |
| Jan 19, 2024 | Eric Lefebvre | CHIEF MEDICAL OFFICER | -10.295K | $17.23 | -$177.38K | SELL | -6.16% | 156.92K | Jan 17 | View |
| Jan 19, 2024 | Mike Ouimette | GENERAL COUNSEL & CORP. SEC'Y | -5.197K | $17.23 | -$89.54K | SELL | -8.60% | 55.246K | Jan 17 | View |
| Aug 07, 2023 | Hans Hull | CHIEF BUSINESS OFFICER | -20.728K | $12.34 | -$604.55K | SELL | -9.03% | 208.84K | Aug 03 - Aug 04 | View |
| Jul 21, 2023 | Mike Ouimette | GENERAL COUNSEL & CORP. SEC'Y | -4.755K | $17.55 | -$83.45K | SELL | -7.29% | 60.443K | Jul 20 | View |
| Jul 19, 2023 | Mike Ouimette | GENERAL COUNSEL & CORP. SEC'Y | -12.778K | $18.01 | -$230.12K | SELL | -16.39% | 65.198K | Jul 17 | View |
| Jul 19, 2023 | Eric Lefebvre | CHIEF MEDICAL OFFICER | -22.321K | $18.01 | -$401.98K | SELL | -11.78% | 167.215K | Jul 17 | View |
| Jul 19, 2023 | Hans Hull | CHIEF BUSINESS OFFICER | -17.937K | $18.01 | -$323.03K | SELL | -7.14% | 233.168K | Jul 17 | View |
| Jul 19, 2023 | Lamont Keith Cummings | CHIEF FINANCIAL OFFICER | -19.771K | $18.01 | -$356.06K | SELL | -8.84% | 203.999K | Jul 17 | View |
| Jul 19, 2023 | Bernard Coulie | PRESIDENT AND CEO | -70.15K | $18.01 | -$1.26M | SELL | -8.54% | 751.42K | Jul 17 | View |
| Apr 03, 2023 | Mike Ouimette | GENERAL COUNSEL & CORP. SEC'Y | -7.751K | $26.62 | -$206.33K | SELL | -13.24% | 50.789K | Mar 30 - Apr 03 | View |
| Apr 03, 2023 | Eric Lefebvre | CHIEF MEDICAL OFFICER | -11.245K | $26.52 | -$298.23K | SELL | -7.16% | 145.786K | Mar 30 | View |
| Apr 03, 2023 | Hans Hull | CHIEF BUSINESS OFFICER | -9.036K | $26.52 | -$239.64K | SELL | -4.02% | 215.949K | Mar 30 | View |
| Apr 03, 2023 | Lamont Keith Cummings | CHIEF FINANCIAL OFFICER | -9.96K | $26.52 | -$264.15K | SELL | -6.29% | 148.47K | Mar 30 | View |
| Apr 03, 2023 | Bernard Coulie | PRESIDENT AND CEO | -35.339K | $26.52 | -$937.22K | SELL | -4.91% | 684.07K | Mar 30 | View |
| Feb 06, 2023 | Bernard Coulie | PRESIDENT AND CEO | 0 | $20.07 | -$830.83K | SELL-OPTIONS | 0.00% | 649.429K | Feb 02 - Feb 03 | View |
| Feb 01, 2023 | Bernard Coulie | PRESIDENT AND CEO | 0 | $19.18 | -$1.38M | SELL-OPTIONS | 0.00% | 649.429K | Jan 30 - Feb 01 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.